Acute lymphoblastic leukemia (ALL) is a fast- growing blood cancer that starts in disease- fighting lymphocytes of your immune system. In ALL, bone marrow makes too many immature lymphocytes called lymphoblasts. Lymphoblasts can crowd out other blood cells causing blood to not work as it should. Acute leukemias grow faster than chronic leukemias. ALL most …
There is more than one treatment for ALL. Not everyone will receive the same treatment. Treatment options are based on many factors. Together, you and your doctor will choose a treatment plan that is right for you. Chemotherapy Chemotherapy is the backbone of ALL treatment and is often combined with other drug therapies. Chemotherapy is …
Myelodysplastic syndromes Myelodysplastic syndromes (MDS) are a rare group of bone marrow disorders. In MDS, the body does not make enough healthy blood cells for the bone marrow. Bone marrow contains parent cells called stem cells. Stem cells can rapidly divide and clone themselves to form new cells. In MDS, some stem cells are abnormal. …
What is multiple myeloma? Multiple myeloma (also simply called myeloma) is a rare type of blood cancer that develops in bones and other areas of the body. Myeloma cells release large amounts of myeloma proteins, which can impair bodily functions (like kidney function). Myeloma cells can also destroy bone tissue, causing high calcium levels, bone …
AML treatment should be done at experienced cancer centers. Treating cancer takes a team of doctors, health care workers, and social care professionals from different professional backgrounds who have knowledge and experience with acute leukemia. Treatment phases There are 3 phases of treatment: induction, consolidation, and maintenance. Induction Induction is the first phase of treatment. …
AML is a cancer of myeloid progenitor cells. Changes in these cells stop myeloid blasts from becoming mature blood cells. As a result, there is a buildup of blasts in the marrow and blood. In turn, there are not enough red blood cells, platelets, and mature granulocytes. To be diagnosed with AML, 20 percent (20%) …
